EP-1229: Overall treatment time and toxicity of IMAT with integrated boost for intermediate or high-risk prostate cancer. (April 2015) - Ferrer, F.; Mendez, M.; Letelier, H.; Boladeras, A.; Piñeiro, R.; Chiruzzi, C.; Galdeano, M.; Najjari, D.; Sancho, I.; Chavez, R.; Picon, C.; Pera, J.; et al.